X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70008) 70008
Book Review (12783) 12783
Publication (2603) 2603
Newsletter (1802) 1802
Magazine Article (512) 512
Conference Proceeding (334) 334
Book Chapter (169) 169
Book / eBook (75) 75
Newspaper Article (73) 73
Dissertation (41) 41
Trade Publication Article (32) 32
Reference (29) 29
Transcript (24) 24
Web Resource (23) 23
Paper (7) 7
Government Document (3) 3
Data Set (2) 2
Archival Material (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58771) 58771
humans (53350) 53350
antihypertensive agents - therapeutic use (38359) 38359
male (32547) 32547
hypertension - drug therapy (30338) 30338
female (27370) 27370
middle aged (21288) 21288
hypertension (20644) 20644
aged (17226) 17226
blood pressure - drug effects (15347) 15347
adult (14859) 14859
animals (14052) 14052
antihypertensive agents - pharmacology (13645) 13645
hypertension - physiopathology (10882) 10882
antihypertensive agents - administration & dosage (10056) 10056
blood pressure (9703) 9703
rats (8826) 8826
peripheral vascular disease (8765) 8765
risk factors (8364) 8364
antihypertensive agents - adverse effects (8355) 8355
pharmacology & pharmacy (8065) 8065
treatment outcome (8023) 8023
hypertension - complications (6973) 6973
abridged index medicus (6701) 6701
antihypertensive drugs (6671) 6671
blood-pressure (6381) 6381
antihypertensive agents (6278) 6278
drug therapy, combination (5769) 5769
medicine, general & internal (5223) 5223
cardiac & cardiovascular systems (5214) 5214
time factors (4528) 4528
aged, 80 and over (4519) 4519
drug therapy (4435) 4435
angiotensin-converting enzyme inhibitors - therapeutic use (4355) 4355
hypertension - diagnosis (3782) 3782
research (3678) 3678
mortality (3535) 3535
hypertension - epidemiology (3474) 3474
double-blind method (3467) 3467
prospective studies (3357) 3357
dose-response relationship, drug (3356) 3356
risk (3215) 3215
follow-up studies (3191) 3191
care and treatment (3179) 3179
prevalence (3140) 3140
heart rate - drug effects (3139) 3139
blood pressure - physiology (3028) 3028
calcium channel blockers - therapeutic use (2946) 2946
hypertension - therapy (2826) 2826
adolescent (2801) 2801
ophthalmology (2742) 2742
clinical trials as topic (2697) 2697
adrenergic beta-antagonists - therapeutic use (2659) 2659
therapy (2633) 2633
retrospective studies (2587) 2587
diuretics - therapeutic use (2560) 2560
management (2558) 2558
medicine & public health (2506) 2506
analysis (2480) 2480
hypertension - etiology (2455) 2455
prevention (2443) 2443
disease (2430) 2430
old medline (2412) 2412
rats, inbred shr (2410) 2410
diuretics (2400) 2400
randomized controlled trials as topic (2264) 2264
health aspects (2215) 2215
angiotensin (2109) 2109
prognosis (2045) 2045
cardiovascular diseases - prevention & control (2035) 2035
angiotensin receptor antagonists (2033) 2033
diabetes (2009) 2009
age factors (2004) 2004
hemodynamics - drug effects (1984) 1984
urology & nephrology (1967) 1967
stroke (1947) 1947
pregnancy (1944) 1944
internal medicine (1942) 1942
rats, sprague-dawley (1845) 1845
patient compliance (1841) 1841
hypertension, pulmonary - drug therapy (1830) 1830
losartan (1828) 1828
drugs (1816) 1816
intraocular pressure - drug effects (1795) 1795
tetrazoles - therapeutic use (1784) 1784
trial (1733) 1733
drug combinations (1729) 1729
hypertension - blood (1710) 1710
practice guidelines as topic (1697) 1697
glaucoma (1690) 1690
antihypertensive agents - pharmacokinetics (1687) 1687
renin-angiotensin system - drug effects (1683) 1683
cross-sectional studies (1667) 1667
cardiovascular disease (1659) 1659
hypertension - prevention & control (1650) 1650
blood pressure monitoring, ambulatory (1639) 1639
rats, wistar (1632) 1632
angiotensin-converting enzyme inhibitors - pharmacology (1599) 1599
hypertension - metabolism (1553) 1553
cardiology (1545) 1545
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (50) 50
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Baycrest Hospital - Wellness Library (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60911) 60911
German (2836) 2836
French (1788) 1788
Russian (1685) 1685
Japanese (1046) 1046
Spanish (988) 988
Italian (799) 799
Chinese (523) 523
Polish (387) 387
Portuguese (227) 227
Swedish (227) 227
Danish (191) 191
Czech (174) 174
Dutch (167) 167
Norwegian (155) 155
Hungarian (147) 147
Romanian (120) 120
Ukrainian (66) 66
Croatian (57) 57
Hebrew (57) 57
Finnish (56) 56
Bulgarian (51) 51
Turkish (43) 43
Serbian (35) 35
Slovak (32) 32
Korean (20) 20
Lithuanian (9) 9
Bosnian (4) 4
Icelandic (2) 2
Slovenian (2) 2
Afrikaans (1) 1
Armenian (1) 1
Greek (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1977, Handbook of experimental pharmacology : New series, ISBN 9783540075943, Volume 39., xiv, 779
Book
1967, Medicinal chemistry, a series of monographs, v. 7, 534
Book
JAMA, ISSN 0098-7484, 11/2004, Volume 292, Issue 18, pp. 2217 - 2225
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Medical Care, ISSN 0025-7079, 4/2009, Volume 47, Issue 4, pp. 395 - 402
Background: Intensification of pharmacotherapy in persons with poorly controlled chronic conditions has been proposed as a clinically meaningful process... 
Hypertension | Hyperlipidemias | Trajectory control | Diabetes mellitus | Ales | Predisposing factors | Medications | Internships | Diabetes | Hemoglobins | Cardiovascular disease | Hyperlipidemia | Quality of health care | UNITED-STATES | cardiovascular disease | hyperlipidemia | quality of health care | MANAGEMENT | CHOLESTEROL | HYPERTENSION CONTROL | TRANSLATING RESEARCH | diabetes mellitus | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | BLOOD-PRESSURE CONTROL | HEALTH POLICY & SERVICES | CORONARY-HEART-DISEASE | hypertension | TYPE-2 DIABETES-MELLITUS | OF-CARE | PERFORMANCE-MEASURES | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Hyperlipidemias - drug therapy | Middle Aged | Risk Factors | Diabetes Mellitus - drug therapy | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | California | Antihypertensive Agents - therapeutic use | Managed Care Programs | Outcome and Process Assessment (Health Care) | Drug Therapy - standards | Hypoglycemic Agents - administration & dosage | Drug Therapy - methods | Hypolipidemic Agents - administration & dosage | Female | Aged | Hypolipidemic Agents - therapeutic use | Quality Indicators, Health Care - standards | Chronic Disease - drug therapy | Performance evaluation | Validity | Drug therapy | Risk factors | Quality of care | Chronic illnesses | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e98961 - e98961
Journal Article
Hypertension, ISSN 0194-911X, 06/2008, Volume 51, Issue 6, pp. 1537 - 1544
Journal Article